Abstract: Disclosed are novel formulations for the treatment of otic infections in an animal comprising a triazole anti-fungal compound, a quinolone antibiotic and a corticosteroid such as mometasone furoate monohydrate.
Type:
Grant
Filed:
August 10, 2005
Date of Patent:
December 27, 2011
Assignee:
Schering-Plough Animal Health Corporation
Inventors:
Abu S Huq, Allan J Weingarten, Robert D Simmons
Abstract: Disclosed is a method for testing a modified specimen such as a dried blood spot, plasma or serum specimen, for an analyte of interest, such as cholesterol. In accordance with the disclosed subject matter, the level of the analyte of interest in the medium from which the modified specimen was obtained (e.g., from a patient's blood) is determined based on the level of an analyte in a solution formed from the modified specimen and on the level of at least one normalizing analyte. The analyte and normalizing analyte each may be an ion, compound, biochemical entity, or property of the specimen. Also disclosed are a fluid collector and a fluid collection device.
Abstract: A method of controlling microorganisms such as lactobacilli metabolism in mash in an ethanol production facility includes adding to the mash an effective amount to control such microorganisms of one or more of a substantially water insoluble pristinamycin-type antimicrobial agent, a substantially water insoluble polyether ionophore antimicrobial agent, or both, wherein the term “substantially water insoluble” means the antimicrobial agent has a solubility in pure water at 20° C. of 0.
Type:
Application
Filed:
May 27, 2011
Publication date:
December 1, 2011
Applicant:
Phibro Animal Health Corporation
Inventors:
David Alan Fowlie, Wayne Mattsfield, Dennis P. Bayrock
Abstract: An improved weight and growth stimulant for domesticated animals such as cattle, pigs and sheep is comprised of an anabolic agent that is subcutaneously administered in the form of a dual release implant formulation. Increased gains are particularly improved when zeranol is administered in an immediate-release and controlled-release formulation which allows for a one-time dosage injection.
Type:
Grant
Filed:
November 25, 2008
Date of Patent:
August 16, 2011
Assignee:
Schering-Plough Animal Health Corporation
Inventors:
Chung Shih, Thomas J. Kennedy, Peter James Knight, Daniel S. Robins, Zezhi Jesse Shao
Abstract: Novel trifluoromethanesulfonanilide oxime ether compounds useful for controlling endo and/or ectoparasites in the environment are provided, together with methods of making the same, and methods of using the inventive compounds to treat parasite infestations in vivo or ex vivo.
Type:
Grant
Filed:
October 31, 2007
Date of Patent:
March 15, 2011
Assignee:
Schering-Plough Animal Health Corporation
Inventors:
Adam Gerhardt Meyer, Kevin Norman Winzenberg, David G. Sawutz, Andris Juris Liepa
Abstract: The invention provides new, specific antigenic peptides from the protein GDF8. The invention also provides fusion proteins comprising the new peptides, immunogens and vaccines based on the new peptides and/or fusion proteins, antibodies that specifically bind to the new peptides of GDF8, and methods of treating animals in order to modulate the activity of GDF8, employing vaccines or antibodies according to the invention.
Type:
Grant
Filed:
August 4, 2009
Date of Patent:
February 22, 2011
Assignee:
Schering-Plough Animal Health Corporation
Abstract: The present application relates to osteopontin (Eta-1) polypeptides, nucleic acids that encode Eta-1, antibodies that specifically bind to Eta-1, and methods for enhancing an immune response in an animal.
Type:
Application
Filed:
June 24, 2010
Publication date:
November 18, 2010
Applicant:
Schering-Plough Animal Health Corporation
Abstract: A system and method to deflect DNS inquires to a new IP address for a website prior to or after the occurrence of a natural disaster that damages the computer infrastructure of an organization, thereby interrupting the organization's ability to continue to offer its website information. An automated process is included that alters a zone file on a controlling DNS server in a manner that provides a minimum of disruption to resolver programs attempting to resolve names of deflected computers via Internet DNS. An intelligent monitor program continually, but periodically, surveys the organization's web server to confirm its operations status and intervenes in the DNS resolution structure for that web server in the event that a sustained disruption occurs.
Abstract: Novel imidazo[1,2-b]pyridazine compounds useful for controlling parasites in animals and methods of treatment of parasite infestation in animals using the compounds are disclosed.
Type:
Grant
Filed:
December 22, 2004
Date of Patent:
July 20, 2010
Assignee:
Schering-Plough Animal Health Corporation
Inventors:
Kevin N. Winzenberg, Craig L. Francis, David G. Sawutz, Ashit Ganguly
Abstract: A radiation attenuation corridor couples a radiation therapy room and a control room. The radiation attenuation corridor is made of a material that substantially absorbs ionizing radiation and substantially blocks the transmission of the ionizing radiation. Specific wall portions at the entrance of the corridor are covered with borated polyethylene (BPE). Specific wall portions diverge from an axis defined by the corridor by from about 10 degrees to about 45 degrees. The corridor thus leads out of the room and angles laterally across the wall of the therapy room, before angling again and opening to a safe room. The added angles in the radiation corridor increase the distance of radiation travel, and make the path more indirect, thereby increasing the contact of the radiation emissions with the radiation shielding and further attenuating the radiation.
Abstract: Please insert the attached Abstract provided herewith on a separate sheet after the claims. The present invention pertains to a method for administering a predetermined amount of a pharmaceutical composition to an animal comprising the steps of taking a cannula suitable for insertion into a nasal cavity of the animal, slidably connecting the cannula to a delivery device which is suitable for holding the pharmaceutical composition, inserting the cannula via a nostril into the nasal cavity such that a peripheral line of the cannula is contiguous with a circumferential line of the nostril, actuating the delivery device to force the said amount of the pharmaceutical composition through the cannula into the nasal cavity, retracting the cannula from the nasal cavity and removing the cannula from the device. The invention also pertains to an apparatus for performing this method, a cannula for use with the apparatus and a kit containing the required components to perform the method.
Type:
Application
Filed:
December 4, 2008
Publication date:
May 27, 2010
Applicants:
SCHERING-PLOUGH ANIMAL HEALTH CORPORATION, SCHERING-PLOUGH LTD., SCHERING-PLOUGH PTY. LIMITED
Abstract: The present invention discloses a canine TSLP protein and a nucleic acid that encodes that protein. Peptide fragments of the protein that comprise specific epitopes of the canine TSLP protein are also disclosed. The canine TSLP protein and related peptide fragments may be used as an antigen for immunological assays, as well as for vaccines that induce anti-TSLP antibodies. The present invention further discloses methods of making and using the canine TSLP gene, the canine TSLP protein, and the related peptide fragments.
Type:
Grant
Filed:
December 11, 2007
Date of Patent:
May 18, 2010
Assignee:
Schering-Plough Animal Health Corporation
Inventors:
Jeanine D. Mattson, Daniel M. Gorman, Rene de Waal Malefyt, Mohamad A. Morsey
Abstract: A system and method for broadcasting messages to selected websites in order to provide emergency information to the U.S. populace, or zone applicable populace, from a central authority. This is achieved by implementing a “partial deflection” of a website altering the applicable zone file on a DNS server having authority over a website. Depending up which authority makes a request for broadcasting an emergency message, an emergency website is created and a partial deflection of the original entity's page is deflected to a main frame accompanying a header frame displaying the emergency alert message the emergency alert webpage. The requesting authority retains control over the content of the emergency message and can trigger the implementation of the broadcast from a variety of signal interfaces.
Abstract: Disclosed is a method for testing a modified specimen such as a dried blood spot, plasma or serum specimen, for an analyte of interest, such as cholesterol. In accordance with the disclosed subject matter, the level of the analyte of interest in the medium from which the modified specimen was obtained (e.g., from a patient's blood) is determined based on the level of an analyte in a solution formed from the modified specimen and on the level of at least one normalizing analyte. The analyte and normalizing analyte each may be an ion, compound, biochemical entity, or property of the specimen. Also disclosed are a fluid collector and a fluid collection device.
Type:
Application
Filed:
September 22, 2009
Publication date:
January 14, 2010
Applicant:
HOME ACCESS HEALTH CORPORATION
Inventors:
Michael Wandell, Ilia Vinogradov, Barbara Godsey
Abstract: Disclosed is a method for testing a modified specimen such as a dried blood spot, plasma or serum specimen, for an analyte of interest, such as cholesterol. In accordance with the disclosed subject matter, the level of the analyte of interest in the medium from which the modified specimen was obtained (e.g., from a patient's blood) is determined based on the level of an analyte in a solution formed from the modified specimen and on the level of at least one normalizing analyte. The analyte and normalizing analyte each may be an ion, compound, biochemical entity, or property of the specimen. Also disclosed are a fluid collector and a fluid collection device.
Type:
Grant
Filed:
November 12, 2003
Date of Patent:
November 3, 2009
Assignee:
Home Access Health Corporation
Inventors:
Michael Wandell, Ilia Vinogradov, Barbara Godsey
Abstract: The invention provides new, specific nucleic acids encoding antigenic peptides from the protein GDF8. The invention also provides nucleic acids encoding fusion proteins comprising the new peptides, immunogens and vaccines based on the nucleic acids encoding new peptides and/or fusion proteins, antibodies that specifically bind to the new peptides of GDF8, and methods of treating animals in order to modulate the activity of GDF8, employing vaccines or antibodies according to the invention.
Type:
Grant
Filed:
April 2, 2008
Date of Patent:
September 8, 2009
Assignee:
Schering-Plough Animal Health Corporation
Abstract: Disclosed is a method for testing a modified specimen such as a dried blood spot, plasma or serum specimen, for an analyte of interest, such as cholesterol. In accordance with the disclosed subject matter, the level of the analyte of interest in the medium from which the modified specimen was obtained (e.g., from a patient's blood) is determined based on the level of an analyte in a solution formed from the modified specimen and on the level of at least one normalizing analyte. The analyte and normalizing analyte each may be an ion, compound, biochemical entity, or property of the specimen. Also disclosed are a fluid collector and a fluid collection device.
Type:
Grant
Filed:
November 5, 2004
Date of Patent:
August 4, 2009
Assignee:
Home Access Health Corporation
Inventors:
Michael Wandell, Ilia Vinogradov, Barbara Godsey, Troy Bervig
Abstract: A system and method for broadcasting messages to selected websites in order to provide emergency information to the U.S. populace, or zone applicable populace, from a central authority. This is achieved by implementing a “partial deflection” of a website altering the applicable zone file on a DNS server having authority over a website. Depending up which authority makes a request for broadcasting an emergency message, an emergency website is created and a partial deflection of the original entity's page is deflected to a main frame accompanying a header frame displaying the emergency alert message the emergency alert webpage. The requesting authority retains control over the content of the emergency message and can trigger the implementation of the broadcast from a variety of signal interfaces.
Abstract: Disclosed is a method for testing a modified specimen such as a dried blood spot, plasma or serum specimen, for an analyte of interest, such as cholesterol. In accordance with the disclosed subject matter, the level of the analyte of interest in the medium from which the modified specimen was obtained (e.g., from a patient's blood) is determined based on the level of an analyte in a solution formed from the modified specimen and on the level of at least one normalizing analyte. The analyte and normalizing analyte each may be an ion, compound, biochemical entity, or property of the specimen. Also disclosed are a fluid collector and a fluid collection device.
Abstract: An improved weight and growth stimulant for domesticated animals such as cattle, pigs and sheep is comprised of an anabolic agent that is subcutaneously administered in the form of a dual release implant formulation. Increased gains are particularly improved when zeranol is administered in an immediate-release and controlled-release formulation which allows for a one-time dosage injection.
Type:
Application
Filed:
November 25, 2008
Publication date:
March 19, 2009
Applicants:
Schering-Plough Animal Health Corporation, Schering-Plough LTD., Schering-Plough PTY. Limited
Inventors:
Chung Shih, Thomas J. Kennedy, Peter James Knight, Daniel S. Robins, Zezhi Jesse Shao